New study to look at health benefits of Z Trim Biofiber Gum

Published: 19-Aug-2014

Will evaluate impact of BFG on Arabinoxylans Oligosaccharides (AXOS) ratios


Z Trim Holdings, a US-based AgriTech company providing functional ingredients to a variety of industries, says a new animal feeding study by an independent laboratory aims to quantify the physiological effects of its Biofiber Gum (BFG) on weight gain and cholesterol.

Prior studies identified such health benefits, using similar but non-commercialised soluble fibre.

Z Trim says the new study will further evaluate BFG's impact on Arabinoxylans Oligosaccharides (AXOS) ratios. Of importance are the physiological effects of AXOS on: liver fat; cholesterol; inflammatory cytokines; bacteria for kidney, heart and colon health; intestinal gene expression; type II diabetes; and obesity.

Previous animal feeding studies on the benefits of ingesting AXOS (the major components of BFG) have shown improved colon health as well as positive effects on the immune system, obesity, cholesterol levels and type II diabetes.

'A recently submitted FDA-protocol to demonstrate the ability of AXOS to decrease the intestinal generation of toxins associated with kidney disease such as indoxyl sulfate and p-cresyl sulfate in healthy individuals, validates our keen interest in exploring the health benefits of BFG,' said Kyle Hanah, VP of Technology at Z Trim.

'After significant R&D, when we finally discovered how to make a commercially viable BFG, we knew we were onto something exceptional that could improve the health of humans and animals alike.'

Steve Cohen, CEO of Z Trim, added: 'This is another key step in the rollout of our soluble fibre product, BFG. We hope that positive data from this study will accelerate the conversations we have initiated with several prominent food, pharmaceutical and nutraceutical manufacturing companies.'

You may also like